Financhill
Sell
32

GRTX Quote, Financials, Valuation and Earnings

Last price:
$0.02
Seasonality move :
-29.3%
Day range:
$0.02 - $0.03
52-week range:
$0.02 - $0.06
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
53.3K
Avg. volume:
93.3K
1-year change:
-35.14%
Market cap:
$1.8M
Revenue:
--
EPS (TTM):
-$0.13

Earnings Data

Next earnings date for GRTX
--
Most recent earnings per share
-$0.01
Missed by $0.01
(Sep 30/2025)
Consensus Estimate
--
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GRTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 -- -- -$0.01 -- --
06/30/2025 Q2 -- -- -$0.01 -- --
05/15/2025 Q1 -- -- -$0.02 -- --
12/31/2024 Q4 -- -- -$0.09 -- --
12/13/2024 Q3 -- -- -$0.10 -- --
08/14/2024 Q2 -- -- -$0.07 -- --
05/13/2024 Q1 -- -- -$0.08 -- --
03/28/2024 Q4 -- -- -$0.03 -- --
11/14/2023 Q3 -- -- -$0.33 -$0.40 $0.07
08/09/2023 Q2 -- -- -$0.48 -$0.38 -$0.10
05/11/2023 Q1 -- -- -$0.50 -$0.43 -$0.07
03/08/2023 Q4 -- -- -$0.58 -$0.51 -$0.07
11/09/2022 Q3 -- -- -$0.60 -$0.50 -$0.10
08/09/2022 Q2 -- -- -$0.54 -$0.51 -$0.03
05/16/2022 Q1 -- -- -$0.58 -$0.60 $0.02
03/10/2022 Q4 -- -- -$0.64 -$0.76 $0.12
11/10/2021 Q3 -- -- -$0.86 -$0.77 -$0.09
08/10/2021 Q2 -- -- -$0.88 -$0.83 -$0.05
05/11/2021 Q1 -- -- -$0.75 -$0.83 $0.08
03/11/2021 Q4 -- -- -$0.80 -$0.68 -$0.12
11/10/2020 Q3 -- -- -$0.69 -$0.77 $0.08
08/10/2020 Q2 -- -- -$0.75 -$0.75 $0.00
05/12/2020 Q1 -- -- -$0.74 -$0.70 -$0.04
03/10/2020 Q4 -- -- -$1.31 -$0.61 -$0.70
09/30/2019 Q3 -- -- -$0.63 -$0.47 -$0.16

Galera Therapeutics, Inc. Earnings Questions

  • How Much did Galera Therapeutics, Inc. Generate in Revenue Last Quarter?

    Galera Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Galera Therapeutics, Inc. Beat Earnings Last Quarter?

    Galera Therapeutics, Inc. announced earnings per share of -$0.01 which represents a miss of analyst forecast a -- per share.

  • Is Galera Therapeutics, Inc. Profitable?

    Galera Therapeutics, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Galera Therapeutics, Inc. EPS Next Year?

    Galera Therapeutics, Inc.'s earnings are forecast to decrease from -$0.35 per share to -- per share next year representing a decrease of -23.48%.

  • When is Galera Therapeutics, Inc.'s Earnings Date?

    Currently, Galera Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 9, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 31.68% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 45.78% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 8.15% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock